Jimini Health provides a clinician-led mental health platform that augments traditional therapy with a clinical-grade, AI-powered assistant named Sage. Sage offers patients continuous, between-session support, such as coping skills practice and mood tracking, while ensuring that all interactions are strictly supervised by licensed human therapists. Pulse 2.0 interviewed Jimini Health co-founder and CEO Luis Voloch to learn more.
Luis Voloch’s Background
Could you tell me more about your background? Voloch said:
“I’ve spent my career at the intersection of AI, bio/healthcare, and entrepreneurship. Before co-founding Jimini Health, I co-founded Immunai, an AI-driven cancer immunotherapy company that has grown into a business valued at more than $1 billion. Prior to that, I worked on AI systems at Palantir and studied mathematics and computer science at MIT, where I earned both my undergraduate and master’s degrees (while on a PhD program in computer science). I also taught about AI and Data Science at Stanford Graduate School of Business.”
“Throughout those experiences, I became increasingly interested in how AI could be deployed responsibly in high-impact, high-complexity, and regulated environments. That ultimately led me to behavioral healthcare, where I saw an opportunity to build technology that helps patients stay engaged in care while keeping clinicians at the center of treatment.”
Formation Of The Company
How did the idea for the company come together? Voloch shared:
“Before Jimini, I spent years building AI systems in healthcare and biotech. One lesson became increasingly clear: the hardest part of healthcare AI is not building the model. It’s deploying that technology safely in environments where patient outcomes, biology, and science are in play, and where regulatory requirements matter.”
“At the same time, we saw millions of people turning to AI for mental health support, often without clinician visibility or oversight. Most mental healthcare still happens through scheduled appointments, even though the moments that determine whether treatment succeeds or fails often happen between sessions. Jimini was founded to bridge that gap by creating a clinician-supervised AI that extends the care team and helps patients stay connected to care between visits.”
Favorite Memory
What has been your favorite memory working for the company so far? Voloch reflected:
“I have frequent, great memories of how receptive and forward-thinking many clinical leaders are to AI. While starting Jimini, I feared it would take longer than it did for most to become ready for clinical AI. Most already get it, and are helping shape the future with us.”
Core Products
What are the company’s core products and features? Voloch explained:
“Jimini Health is building clinician-supervised AI infrastructure for behavioral health systems. Our core product is Sage, a patient-facing AI designed to function as a member of the care team rather than a standalone chatbot.”
“Sage provides continuous support between appointments, reinforces evidence-based therapies, helps patients stay on track with treatment plans and medications, and proactively checks in around relevant life events and stressors. Every interaction is grounded in a patient’s care plan and supervised by a licensed clinician, who maintains visibility into how Sage is supporting the patient.”
Challenges Faced
Have you faced any challenges in your sector of work recently? Voloch acknowledged:
“One of the biggest challenges is that AI adoption in mental health is moving faster than the healthcare system itself. Patients are already using general-purpose AI tools for emotional support, but those systems were never designed for clinical care and often operate without clinician involvement. Whereas not all systems are ready yet, we have been impressed by how forward-thinking the average clinical leader and executive is to Sage.”
Evolution Of The Company’s Technology
How has the company’s technology evolved since launching? Voloch noted:
“From the beginning, our goal was to build a clinician-supervised AI system that supports patients between sessions while keeping clinicians informed and in control. One way in which it has evolved is that Sage is a lot more flexible in how it can collaborate with clinicians and patients; it can be reactive and proactive, flexible to various care settings and diagnoses, and also communicate with clinicians in various ways (sharing information and escalation, receiving information and instructions, answering questions, etc.”
“A major part of that evolution has come from operating our own clinic. That real-world environment allows us to evaluate every model update against patient outcomes and clinician feedback, rather than relying solely on benchmarks or controlled pilots.”
Significant Milestones
What have been some of the company’s most significant milestones? Voloch cited:
“Several milestones stand out. One was building and operating our own clinic, which allowed us to validate Sage in real clinical settings and create a continuous feedback loop between patients, clinicians, and product development.”
“Another was beginning to work with behavioral health organizations that shared our belief that AI should be integrated into care delivery with clinicians remaining in control. Those early partnerships helped demonstrate that healthcare systems are actively looking for ways to deploy patient-facing AI safely and responsibly.”
“Looking ahead, we’re focused on expanding those partnerships and helping larger provider organizations adopt this care model at scale.”
Customer Success Stories
Can you share any specific customer success stories? Voloch highlighted:
“While we’re not sharing details about specific provider organizations at this time, we’ve seen strong early results around patient engagement and adherence.”
“Early data show significant improvement in patient adherence to care, one of the most important predictors of long-term outcomes in behavioral health. We’ve also seen strong patient acceptance and clinician engagement across deployments. For us, those results reinforce the idea that continuous support between sessions can play a meaningful role in helping patients stay connected to treatment. We will work to publish many of these results.”
Funding/Revenue
Are you able to discuss funding and/or revenue metrics? Voloch revealed:
“Jimini Health has raised more than $25 million to date, including a recently announced $17 million seed round led by M13, with participation from Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind.”
“The funding will support continued expansion of Sage across additional care settings and partnerships with large behavioral health organizations.”
Total Addressable Market (TAM)
What total addressable market (TAM) size is the company pursuing? Voloch assessed:
“Behavioral healthcare represents one of the largest unmet needs in healthcare today. Demand for mental health services continues to grow, while provider organizations face increasing pressure to improve access, engagement, and outcomes with limited clinical resources. The TAM is hundreds of billions of dollars.”
“Our focus is less on a specific market-size figure and more on helping healthcare organizations safely deploy AI as part of care delivery. We believe clinician-supervised AI will become an increasingly important part of how behavioral health services are delivered in the years ahead.”
Differentiation From The Competition
What differentiates the company from its competition? Voloch affirmed:
“Most AI tools either help just the clinician behind the scenes, or help patients as standalone tools. We believe Jimini represents a new category of AI in healthcare: clinically integrated, patient-facing AI that supports both patients and clinicians.”
“One of the biggest differences is that we built and operate our own clinic. Rather than testing Sage solely in controlled environments, our clinicians use the platform with real patients. That gives us a continuous feedback loop to evaluate safety, improve workflows, and understand how AI is actually being used between appointments.”
“Sage is also designed specifically to operate within healthcare organizations and alongside human clinicians. It operates within a patient’s treatment plan, keeps clinicians in control of care decisions, and provides visibility into every patient interaction. We believe clinician oversight, accountability, and safety are essential requirements for AI in behavioral healthcare.”
Future Company Goals
What are some of the company’s future goals? Voloch emphasized:
“Our focus is on expanding partnerships with large behavioral health provider organizations and advancing Sage across additional clinical scenarios, care settings, and patient populations.”
“We’re also continuing to invest in clinical research and evidence generation, helping to establish best practices for the safe deployment of AI in behavioral healthcare. More broadly, we want to help define what responsible, clinician-supervised AI looks like as these technologies become an increasingly important part of healthcare delivery.”
Additional Thoughts
Any other topics you would like to discuss? Voloch concluded:
“Most conversations about AI in healthcare still focus on whether AI should become part of care delivery, but I believe that debate is over. Patients are already using AI for mental health support weekly, typically without clinician visibility or safeguards.”
“I believe the more important question is what role healthcare organizations will play in shaping the use of that technology and how to ensure clinicians remain involved and supervise the process. Organizations that move early to define responsible, clinician-supervised models will help establish the standards the rest of the industry ultimately follows. Our goal at Jimini is to help with just that.”
